Pipes Feed Preview: ClinicalTrials.gov: COVID-19 | Last update posted in the last 14 days

  1. Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Long COVID-19 Syndrome; Long COVID; Long COVID Syndrome
    Interventions: Other: Rehabilitation program
    Sponsors: Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
    Completed

  2. Pericardial Histopathology and COVID-19 Seropositivity

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Inflammatory Response; COVID-19; Pericardial Disease
    Sponsors: Samsun University
    Completed

  3. Characteristics of Postinfectious Cough

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Cough
    Sponsors: Kefang Lai
    Completed

  4. Pancoronavirus Vaccine Study in Healthy Adults

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Respiratory Infection; SARS CoV 2 Infection; COVID-19 Vaccine
    Interventions: Biological: CoV-RBD-scNP-001 and 3M-052-AF
    Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting

  5. Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Drug: ALG-097558; Drug: Dabigatran; Drug: Itraconazole; Other: Placebo
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting

  6. Evaluation of Tuberculosis Treatment Outcomes

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Tuberculosis
    Interventions: Other: Patients with turberculosis
    Sponsors: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
    Completed

  7. Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Post COVID-19

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Covid19
    Interventions: Device: GID SVF-2 Device System
    Sponsors: GID BIO, Inc.
    Withdrawn

  8. Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long COVID Syndrome; Long COVID-19 Syndrome; PASC; PASC Post Acute Sequelae of COVID 19
    Interventions: Device: accelerated intermittent theta burst stimulation
    Sponsors: University of New Mexico; The Mind Research Network; United States Department of Defense
    Not yet recruiting

  9. Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Behavioral: Health Education Initiative
    Sponsors: University of Miami; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Completed

  10. Mind-Body in Long COVID and Myalgic Encephalomyelitis Study (MILES): A Patient-Centred RCT

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Interventions: Other: Dynamic neural retraining system
    Sponsors: University of Alberta; College of Physicians and Surgeons of Alberta
    Not yet recruiting

  11. Feasibility of an Augmented Two-Day Step Test and Causal Modeling for Post-Exertional Symptom Exacerbation in Post Covid-19 Syndrome

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: Long COVID
    Interventions: Device: Portable mask for respiratory gas analysis; Device: Cardio-pulmonary exercise test
    Sponsors: Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel, Jette, Belgium
    Recruiting

  12. Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

    Sun, 20 Apr 2025 04:00:00 -0000

    Conditions: Neuro-PASC; Long COVID
    Sponsors: VA Office of Research and Development; James H. Quillen Department of Veterans Affairs Medical Center
    Recruiting

  13. Are Pediatric Patients' Dental Anxiety Levels Affected by Covid -19 Clinical Conditions?

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Anxiety, Dental
    Interventions: Other: oral examination
    Sponsors: Gazi University
    Completed

  14. PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Post Acute Sequelae of COVID-19
    Interventions: Drug: 11C-PS13
    Sponsors: National Institute of Mental Health (NIMH)
    Recruiting

  15. B Cell Responses in COVID-19

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID 19
    Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia
    Completed

  16. NE3107 in Adults With Long COVID

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: Long COVID
    Interventions: Drug: NE3107; Drug: Placebo
    Sponsors: BioVie Inc.
    Recruiting

  17. EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: COVID - 19
    Interventions: Drug: Colchicine 0.5 MG Oral Tablet
    Sponsors: Zaeema Kanwal
    Recruiting

  18. Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Healthy
    Interventions: Biological: LVT-001; Biological: Cormirnaty
    Sponsors: ANRS, Emerging Infectious Diseases; University Hospital, Tours (Cosponsor); UMS 54 MART; INSERM CIC 1415; LovalTech; INSERM U1259 MAVIVHe; BioMAP - UMR ISP 1282 - Tours University - INRAE; Virology unit, University Hospital, Tours; I-REIVAC Innovative Clinical Research Network In Vaccinology
    Not yet recruiting

  19. A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Biological: CVXGA (CVXGA50); Biological: COMIRNATY®
    Sponsors: CyanVac LLC; Biomedical Advanced Research and Development Authority
    Recruiting

  20. Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Influenza A; Influenza B
    Interventions: Diagnostic Test: COVID/Flu Detect™ Rapid Self-Test
    Sponsors: InBios International, Inc.
    Active, not recruiting

  21. A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV2; COVID-19
    Interventions: Biological: VXA-CoV2-3.1; Biological: COMIRNATY®
    Sponsors: Vaxart
    Active, not recruiting

  22. A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Coronavirus Disease (COVID-19)
    Interventions: Drug: Molnupiravir; Drug: Placebo
    Sponsors: Merck Sharp & Dohme LLC
    Recruiting

  23. Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US Hospitals

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: In-hospital Mortality; Non-COVID Deaths; Surge
    Interventions: Other: COVID-19 Surge
    Sponsors: National Institutes of Health Clinical Center (CC)
    Active, not recruiting

  24. Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Sars-CoV-2 Infection; Coronavirus Infections; COVID-19
    Interventions: Drug: Baricitinib; Other: Placebo
    Sponsors: Wes Ely; National Institutes of Health (NIH); National Institute on Aging (NIA)
    Recruiting

  25. Community-based Behavioral Intervention to Increase Vaccination Using MOST

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: COVID 19; Influenza
    Interventions: Behavioral: Health education on COVID and flu vaccination; Behavioral: Nurse-led shared decision-making; Behavioral: Text messages; Behavioral: Lottery prize for vaccination; Behavioral: Peer navigation
    Sponsors: New York University; Northern Manhattan Improvement Corporation
    Withdrawn

  26. A Study of Apabetalone in Subjects With Long -COVID

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Post-Acute COVID-19 Syndrome
    Interventions: Drug: Apabetalone
    Sponsors: Resverlogix Corp
    Recruiting

  27. tVNS in Long COVID-19

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Chronic Fatigue Syndrome
    Interventions: Device: Transcutaneous vagus nerve stimulator
    Sponsors: Icahn School of Medicine at Mount Sinai
    Recruiting

  28. Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: Post-COVID Postural Orthostatic Tachycardia Syndrome
    Interventions: Biological: IgPro20; Biological: Placebo
    Sponsors: CSL Behring
    Recruiting

  29. RECOVER-SLEEP: Platform Protocol

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long COVID-19; Hypersomnia; Sleep Disturbance
    Interventions: Drug: Modafinil; Drug: Modafinil Placebo; Drug: Solriamfetol; Drug: Solriamfetol Placebo; Drug: Melatonin; Drug: Melantonin Placebo; Device: Tailored lighting (TL) Active; Device: Tailored lighting (TL) Placebo
    Sponsors: Duke University
    Recruiting

  30. RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long COVID-19; Sleep Disturbance
    Interventions: Drug: Melatonin; Drug: Melantonin Placebo; Device: Tailored lighting (TL) Active; Device: Tailored lighting (TL) Placebo
    Sponsors: Duke University
    Recruiting

  31. RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long COVID-19; Hypersomnia
    Interventions: Drug: Modafinil; Drug: Modafinil Placebo; Drug: Solriamfetol; Drug: Solriamfetol Placebo
    Sponsors: Duke University
    Recruiting

  32. RECOVER-AUTONOMIC Platform Protocol

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long Covid19; Long Covid-19
    Interventions: Drug: IVIG + Coordinated Care; Drug: IVIG Placebo + Coordinated Care; Drug: Ivabradine + Coordinated Care; Drug: Ivabradine Placebo + Coordinated Care; Drug: IVIG + Usual Care; Drug: IVIG Placebo + Usual Care; Drug: Ivabradine + Usual Care; Drug: Ivabradine Placebo + Usual Care
    Sponsors: Kanecia Obie Zimmerman
    Recruiting

  33. Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Drug: CD40.RBDv vaccin (SARS-Cov2 Vaccin)
    Sponsors: ANRS, Emerging Infectious Diseases; Vaccine Research Institute (VRI), France; EnnoDc (previously known as LinKinVax)
    Recruiting

  34. SMILE: Clinical Trial to Evaluate Mindfulness as Intervention for Racial and Ethnic Populations During COVID-19

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Anxiety; COVID-19 Pandemic
    Interventions: Behavioral: Mindfulness
    Sponsors: University of North Carolina, Chapel Hill; National Institute on Minority Health and Health Disparities (NIMHD); RTI International
    Recruiting

  35. Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Behavioral: COVID-19 Group Problem Solving; Behavioral: Standard of Care; Behavioral: Booster session
    Sponsors: The University of Texas Health Science Center, Houston; National Institute on Minority Health and Health Disparities (NIMHD)
    Completed

  36. Prevalence and Risk Factors of Anxiety and Depression Among Policemen During the Health Crisis Linked to COVID-19

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Anxiety Syndrome; Depression Syndrome; Policemen
    Sponsors: University Hospital, Strasbourg, France
    Completed

  37. Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: Immunosuppression; COVID-19
    Interventions: Biological: NVX-CoV2372
    Sponsors: University of Wisconsin, Madison; Novavax
    Completed

  38. A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: Covid-19
    Interventions: Drug: nirmatrelvir, ritonavir
    Sponsors: Pfizer
    Completed

  39. A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Procedure: Bronchoscopies and Bronchoalveolar Lavages (BALs); Diagnostic Test: Chest Tomography (CT); Diagnostic Test: Electrocardiogram (ECG); Diagnostic Test: Pulmonary function tests (PFTs); Diagnostic Test: 6 minute walk test (6MWT)
    Sponsors: Mayo Clinic
    Recruiting

  40. RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Long COVID-19; Long COVID
    Interventions: Drug: Paxlovid 25 day dosing; Drug: Paxlovid 15 day dosing; Drug: Control
    Sponsors: Kanecia Obie Zimmerman
    Completed

  41. PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2
    Interventions: Drug: Upamostat; Drug: Placebo (PO)
    Sponsors: Henry M. Jackson Foundation for the Advancement of Military Medicine; Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies; RedHill Biopharma Limited; FHI Clinical, Inc.
    Active, not recruiting

  42. The Effect of Smart Sensor Combined With APP for Individualized Precise Exercise Training in Long Covid-19

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: Coronavirus Disease; COVID-19; Long Covid-19; Telerehabilitation
    Interventions: Device: KNEESUP smart knee assistive device + KNEESUP care APP; Behavioral: Healthy consulation
    Sponsors: Shang-Lin Chiang
    Completed

  43. Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Biological: SARS-CoV-2 DNA Vaccine (ICCOV)
    Sponsors: Immuno Cure 3 Limited; The University of Hong Kong
    Completed

  44. Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2 Infection
    Interventions: Drug: S-217622; Drug: Placebo
    Sponsors: Shionogi
    Completed

  45. Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2; COVID-19; Post-Acute COVID-19 Syndrome
    Interventions: Biological: Pfizer-BioNTech COVID-19 mRNA vaccine
    Sponsors: Pfizer
    Active, not recruiting

  46. Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Disabilities Multiple
    Interventions: Behavioral: ENGAGE
    Sponsors: University of Illinois at Chicago; National Center for Advancing Translational Sciences (NCATS)
    Recruiting

  47. Effect of a Health Pathway for People With Persistent Symptoms Covid-19

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Other: usual care and follow-up by a nurse; Other: Personalized Multifactorial Intervention (IMP)
    Sponsors: Centre Hospitalier Universitaire de Saint Etienne
    Recruiting

  48. Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Emotional Distress; Prosocial Behavior; Pandemic, COVID-19; Coping Skills; Social Support
    Interventions: Behavioral: JoH-C19; Behavioral: Switch off Get Active
    Sponsors: University of Illinois at Urbana-Champaign; Save the Children; Care Connections Mental Wellness and Learning Center; Dickinson Independent School District; Bay District Schools; University of Houston; Baylor College of Medicine; University of South Florida; National Institute of Mental Health (NIMH); Coalition for Compassionate Schools; Boys and Girls Club of Manatee County; Communities in Schools of Galveston County; Communities in Schools Palm Beach; Communities in Schools Gulf South; R'Club Child Care Inc.; Boys and Girls Clubs of Tampa Bay
    Recruiting

  49. The Roles of Vitamin D and Microbiome in Children With Post-acute COVID-19 Syndromes (PACS) and Long COVID

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: Post-acute COVID-19 Syndromes
    Interventions: Other: Vitamin D; Other: Placebo
    Sponsors: China Medical University Hospital
    Completed

  50. Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Viral Lung Infection and Acute Respiratory Failure
    Interventions: Drug: Tozorakimab; Drug: Placebo
    Sponsors: AstraZeneca
    Recruiting

  51. Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Drug: Paxlovid; Drug: Other; Other: Other
    Sponsors: Unity Health Toronto; Health Canada; Canadian Institutes of Health Research (CIHR)
    Recruiting

  52. RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Long COVID; Long Covid19
    Interventions: Drug: Experimental: Paxlovid 25 day dosing; Drug: Experimental: Paxlovid 15 day dosing; Drug: Placebo Comparator: Control
    Sponsors: Kanecia Obie Zimmerman
    Completed

  53. Cognitive Rehabilitation in Post-COVID-19 Condition

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Behavioral: Goal Management Training (GMT)
    Sponsors: Lovisenberg Diakonale Hospital; University of Oslo; Icahn School of Medicine at Mount Sinai; University of Toronto; UiT The Arctic University of Norway; Oslo University Hospital
    Active, not recruiting

  54. Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST): Prospective COVID-19 Natural History Study

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Heart Disease
    Sponsors: National Human Genome Research Institute (NHGRI)
    Completed

  55. Olfactory Training in COVID-19 Associated Loss of Smell

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Hyposmia
    Interventions: Device: Sniffin' sticks Duftquartett
    Sponsors: Medical University Innsbruck
    Completed

  56. α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Other: Real-time Quaking-Induced Conversion (RT-QuIC)
    Sponsors: Medical University Innsbruck
    Completed

  57. COVID-19 Observational Research Collaboratory

    Sun, 20 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; SARS-CoV-2 Infection
    Sponsors: VA Office of Research and Development; Johns Hopkins University
    Completed

  58. Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases

    Sun, 20 Apr 2025 04:00:00 -0000

    Conditions: BCG Vaccination Reaction; Infections; Inflammation; COVID-19
    Interventions: Biological: BCG; Biological: Placebo vaccine
    Sponsors: Radboud University Medical Center; UMC Utrecht
    Active, not recruiting

  59. Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Multiple Sclerosis; Autoimmune Blistering Disease; B-Cell Deficiency
    Interventions: Biological: COVID19 vaccine
    Sponsors: Yale University; National Institute of Allergy and Infectious Diseases (NIAID); Robert Leet and Clara Guthrie Patterson Trust
    Active, not recruiting

  60. AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2
    Interventions: Drug: AZD7442
    Sponsors: AstraZeneca
    Completed

  61. Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Post COVID-19
    Interventions: Other: Evaluation of Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
    Sponsors: Istanbul Arel University
    Completed

  62. Evaluating Public Health Interventions to Improve COVID-19 Testing Among Underserved Populations

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Behavioral: Public Health Intervention Package
    Sponsors: Kathleen Fairfield; MaineHealth
    Completed

  63. Impact of Lp299v on Vascular Function in Patients With PASC

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Other: Lactobacillus Plantarum 299v Freeze Dried Capsule; Other: Freeze Dried Potato Starch Capsule
    Sponsors: Medical College of Wisconsin
    Active, not recruiting

  64. Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: Kidney Transplant Recipient
    Interventions: Biological: Janssen Ad26.CoV2.S Vaccine; Other: Reduction in Immunosuppression Medication; Other: Maintenance in Immunosuppression Medication
    Sponsors: Mark Stegall; Janssen Scientific Affairs, LLC
    Completed

  65. Almitrine in COVID-19 Patients With ARDS Treated by HFNO

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: ARDS; Hypoxemia
    Interventions: Drug: Administration of Almitrine
    Sponsors: Centre Hospitalier Universitaire de Nice
    Completed

  66. Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Corona Virus Infection
    Interventions: Biological: Pfizer-BioNTech mRNA COVID-19 vaccine
    Sponsors: University of Michigan; The Wallace Foundation
    Completed

  67. A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2
    Interventions: Drug: Sodium Chloride; Biological: NDV-HXP-S IN low dose; Biological: NDV-HXP-S IM low dose; Biological: NDV-HXP-S IN high dose; Biological: NDV-HXP-S IM high dose
    Sponsors: Sean Liu
    Completed

  68. Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Testing; Children, Preschool; Parents; Child Development; Self-Control; Exercise; Diet, Healthy
    Interventions: Behavioral: CHILD back-to-ECE COVID-19 saliva testing; Behavioral: ECE personnel back-to-ECE COVID-19 saliva screening; Behavioral: SAGE garden programming
    Sponsors: Arizona State University
    Completed

  69. Partnerships to Address COVID-19 Inequities

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Behavioral: Crowdsourced campaign package; Behavioral: Standard information
    Sponsors: Wake Forest University Health Sciences
    Recruiting

  70. The Effect of Whole Body Vibration Training in Individuals With Post COVID - 19

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Other: whole body vibration training; Other: home based exercises
    Sponsors: Istanbul University - Cerrahpasa
    Completed

  71. Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: Adenovirus Infection; BK Virus Infection; Cytomegaloviral Infection; Hematopoietic and Lymphoid Cell Neoplasm; JC Virus Infection; Malignant Solid Neoplasm; Symptomatic COVID-19 Infection Laboratory-Confirmed
    Interventions: Biological: Virus-specific Cytotoxic T-lymphocytes
    Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
    Recruiting

  72. International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo; Partnership for Clinical Research in Guinea/Partenariat de Recherche Clinique en Guinée (PREGUI); Partnership for Research on Ebola Virus in Liberia (PREVAIL); University Clinical Research Center, Mali; Onom Foundation and Liver Center; Mexican Emerging Infectious Diseases Clinical Research Network; Ina-Respond
    Active, not recruiting

  73. A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Prevention
    Interventions: Biological: Ad26.COV2.S; Other: Placebo; Biological: Influenza Vaccine
    Sponsors: Janssen Vaccines & Prevention B.V.
    Completed

  74. A Study of Baricitinib (LY3009104) in Children With COVID-19

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: Covid19; Corona Virus Infection
    Interventions: Drug: Baricitinib
    Sponsors: Eli Lilly and Company
    Recruiting

  75. Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Posttraumatic Stress Disorder
    Interventions: Behavioral: CPT-Text; Behavioral: Culturally Informed Trauma Treatment (CITT); Behavioral: Retention Incentive; Behavioral: Reminder as Usual
    Sponsors: Stanford University; The University of Texas Health Science Center at San Antonio; Talkspace; National Institute of Mental Health (NIMH); University of Pennsylvania
    Recruiting

  76. A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Upper Respiratory Infection; Lower Respiratory Infection
    Interventions: Device: Fitbit; Device: Douglas Bag; Device: Periflux 6000 EPOS; Device: BIOPAC; Device: Flowmet; Device: NIRS
    Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  77. Cognitive Training in Survivors of Covid-19: A Randomized Trial

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Covid19; Cognitive Impairment
    Interventions: Behavioral: AKL-T01; Other: Control Group
    Sponsors: Vanderbilt University Medical Center
    Completed

  78. Natural History Study of COVID-19 Using Digital Wearables

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Virus Disease
    Sponsors: National Institute on Minority Health and Health Disparities (NIMHD)
    Completed

  79. Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: SARS-CoV-2; Covid19; Corona Virus Infection; Infectious Disease Transmission, Vertical; Pregnancy
    Interventions: Other: No intervention
    Sponsors: Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
    Completed

  80. Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

    Sun, 20 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Biological: Ad26.COV2.S; Biological: BNT162b2; Biological: mRNA-1273; Biological: mRNA-1273.211; Biological: mRNA-1273.222; Biological: SARS-CoV-2 rS/M1
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
    Completed

  81. Neuroinflammation in COVID-19 and Depression

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: Major Depressive Episode; Covid19
    Interventions: Other: [18F]FEPPA PET scan; Other: [11C]SL25.1188 PET scan
    Sponsors: Centre for Addiction and Mental Health
    Completed

  82. Prophylaxis and Treatment of COVID-19

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Acute Respiratory Infection
    Sponsors: Henry M. Jackson Foundation for the Advancement of Military Medicine; Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies
    Completed

  83. Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Healthy Volunteer
    Sponsors: National Institute of Mental Health (NIMH)
    Completed

  84. The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

  85. COVID-19: Post-covid Olfactory Disorders Assessment

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: Olfaction Disorders
    Sponsors: Centre Hospitalier Universitaire de Nice
    Completed

  86. Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: Covid19
    Interventions: Drug: Cytotoxic T Lymphocytes
    Sponsors: Thomas Jefferson University; Tevogen Bio Inc
    Completed

  87. A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)

    Tue, 29 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Prevention
    Interventions: Biological: Ad26.COV2.S
    Sponsors: Janssen Vaccines & Prevention B.V.
    Completed

  88. A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Multiple Sclerosis; COVID-19 (Severe Coronavirus Disease 2019)
    Interventions: Other: data collection; Other: analysis of blood samples
    Sponsors: University Hospital, Basel, Switzerland; Swiss Multiple Sclerosis Registry
    Completed

  89. Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Interventions: Other: Hospitalization
    Sponsors: Assistance Publique - Hôpitaux de Paris
    Completed

  90. Effects of Wearing a Face Mask During CrossFit Exercise

    Thu, 24 Apr 2025 04:00:00 -0000

    Conditions: Dyspnea
    Interventions: Other: High intensity interval training; Other: Continuous exercise training
    Sponsors: University of Saskatchewan
    Withdrawn

  91. STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During and Beyond COVID-19

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Stress; Trauma; Mental Health Issue; Healthcare Workers
    Interventions: Behavioral: Supportive Trauma Exposure Preparation Program
    Sponsors: Unity Health Toronto; Providence Healthcare
    Completed

  92. COVID-19 Neurological Disease: A Prospective Study

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: Diseases of the Nervous System; Other Specified Viral Diseases
    Interventions: Other: Primary exposure is hypoxia (no intervention)
    Sponsors: University of Liverpool; Christian Medical College, Vellore, India; Instituto Autoimune, Brazil; University College London Hospitals; Oswaldo Cruz Foundation; Kamuzu University of Health Sciences; National Institute of Mental Health and Neuro Sciences, India; Encephalitis Society, UK
    Completed

  93. Inspiratory Effort in COVID-19

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Acute Respiratory Failure; Covid19
    Sponsors: University of Modena and Reggio Emilia
    Recruiting

  94. Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Infection; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Neuropathy
    Interventions: Other: Quality-of-Life Assessment; Other: Questionnaire Administration
    Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
    Active, not recruiting

  95. The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: Covid19
    Sponsors: ClinAmygate
    Completed

  96. The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Infection; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
    Interventions: Other: Quality-of-Life Assessment; Other: Survey Administration
    Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
    Recruiting

  97. Telehealth Intervention Program for Older Adults

    Wed, 16 Apr 2025 04:00:00 -0000

    Conditions: Depression, Anxiety; Cognitive Impairment; Stress
    Interventions: Behavioral: Telehealth phone calls; Other: Volunteer of TIP-OA Program; Other: Stakeholder of TIP-OA Program
    Sponsors: Lady Davis Institute
    Recruiting

  98. Breastfeeding Education in the Time of COVID-19

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Breastfeeding; Breastfeeding, Exclusive; Breastfeeding Jaundice; Educational Problems
    Interventions: Behavioral: Telesimulation
    Sponsors: University of California, Davis
    Completed

  99. Effect of COVID-19 on Platelet Aggregation

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; SARS-CoV-2
    Interventions: Other: venipuncture in peripheral vein
    Sponsors: University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
    Completed

  100. Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: Coronavirus Infection; COVID-19
    Interventions: Diagnostic Test: Point-of-care test for SARS-CoV-2
    Sponsors: Manchester University NHS Foundation Trust
    Completed

  101. Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

    Fri, 25 Apr 2025 04:00:00 -0000

    Conditions: Acute Respiratory Distress Syndrome; COVID-19
    Interventions: Procedure: Stellate Ganglion Block
    Sponsors: West Virginia University
    Completed

  102. Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms

    Thu, 17 Apr 2025 04:00:00 -0000

    Conditions: COVID-19; Healthy Control
    Interventions: Device: ADAM Sensor
    Sponsors: Shirley Ryan AbilityLab
    Completed

  103. NCI COVID-19 in Cancer Patients, NCCAPS Study

    Wed, 23 Apr 2025 04:00:00 -0000

    Conditions: COVID-19 Infection; Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm
    Interventions: Procedure: Biospecimen Collection; Other: Data Collection; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
    Sponsors: National Cancer Institute (NCI)
    Active, not recruiting

  104. Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions

    Tue, 22 Apr 2025 04:00:00 -0000

    Conditions: COVID-19
    Sponsors: National Institute of Dental and Craniofacial Research (NIDCR)
    Completed

  105. Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

    Sun, 27 Apr 2025 04:00:00 -0000

    Conditions: Coronavirus
    Interventions: Other: observational
    Sponsors: Mayo Clinic; Society of Critical Care Medicine; Boston University
    Completed

  106. The Impact of Camostat Mesilate on COVID-19 Infection

    Fri, 18 Apr 2025 04:00:00 -0000

    Conditions: Corona Virus Infection
    Interventions: Drug: Camostat Mesilate; Drug: Placebo oral tablet
    Sponsors: University of Aarhus
    Completed

  107. Viral Infections in Healthy and Immunocompromised Hosts

    Wed, 30 Apr 2025 04:00:00 -0000

    Conditions: Anogenital Herpes; COVID-19; Herpes Labialis
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting